-transparent.png){kind=logo}
The purpose of the present study is to show anomalies of the plasma cAMP response of patients with hepatic disorders to a single injection of a low dose of glucagon (1 microgram/kg body wt). The response was markedly blunted in patients with liver cirrhosis and potentiated in patients with acute or chronic hepatitis. This glucagon test is, therefore, promising for development as a simple diagnostic means without undertaking liver biopsy to distinguish cirrhosis from chronic hepatitis.
Related Publications
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
January 1977,
British medical journal,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
March 1984,
Zeitschrift fur Gastroenterologie,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
September 1974,
Clinical science and molecular medicine,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
August 1984,
Journal of clinical gastroenterology,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
July 1979,
Gastroenterology,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
October 1985,
Acta medica Okayama,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
April 1976,
British medical journal,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
April 1986,
Cancer research,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
January 1981,
International pharmacopsychiatry,
H Maekubo, and
T Matsushima, and
F Okada, and
M Honma, and
M Ui
November 1986,
Revista clinica espanola,
